AGP Executive Report
Last update: 9 hours agoPatient Safety & Quality: England’s NHS logged 403 “never events” (Apr 2025–Mar 2026), including wrong-site procedures and foreign objects left inside patients, including gloves. Insurance & Access: A new poll says 47% of voters blame corporate health insurers for rising costs, with most worried about denials/delays and too much insurer control. Opioid Treatment Rules: The DEA finalized changes removing a separate waiver for qualified practitioners to prescribe medications for opioid use disorder treatment. Diabetes Continuity: UK’s Levemir is being discontinued; patients are urged to book insulin review appointments before Sept 2026. Mental Health Focus: HRW challenges secrecy around U.S.-Liberia health aid terms tied to data and surveillance, while multiple reports highlight major gaps in mental health infrastructure and support. Public Health & Food Safety: Kerala warns about Shigella spread; New Zealand recalls undercooked “Death by Chicken” burger and Chicken Katsu salad. Innovation in Care: Resmed completes its acquisition of Noctrix to expand nonpharmacologic wearable treatment for restless legs syndrome. Community Prevention: Ireland’s “Your Health Matters” cancer roadshow returns to Thurles with free screenings and nurse support.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
